Tobacco treatment clinics in urban public housing: feasibility and outcomes of a hands-on tobacco dependence service in the community.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
05 08 2021
Historique:
received: 15 09 2020
accepted: 28 07 2021
entrez: 6 8 2021
pubmed: 7 8 2021
medline: 10 8 2021
Statut: epublish

Résumé

As a further extension of smoke-free laws in indoor public places and workplaces, the Department of Housing and Urban Development's declaration to propose a regulation that would make housing units smoke-free was inevitable. Of note is the challenge this regulation poses to current tenants of housing units who are active smokers. We aimed to assess the efficacy of a tobacco treatment clinic in public housing. The utilization of the clinic by tenants and tenants' respective outcomes regarding smoking status were used to determine the intervention's effectiveness. Tobacco treatment clinics were held in two urban-based housing units for 1-year. The clinics provided on-site motivational interviewing and prescriptions for pharmacological agents if warranted. Outcomes collected include the tenants' clinic attendance and 3- and 6-month self-reported smoking status. Twenty-nine tobacco treatment clinic sessions were implemented, recruiting 47 tenants to participate in smoking cessation. The mean age of the cohort was 53 ± 12.3 years old. Of the 47 tenants who participated, 21 (44.7%) attended three or more clinic sessions. At the 3-month mark, five (10.6%) tenants were identified to have quit smoking; at 6-months, 13 (27.7%) tenants had quit smoking. All 13 of the tenants who quit smoking at the end of 6-months attended three or more sessions. An on-site tobacco treatment clinic to provide strategies on smoking cessation was feasible. Efforts are warranted to ensure more frequent follow-ups for tenants aiming to quit smoking. While further resources should be allocated to help tenants comply with smoke-free housing units' regulations, we believe an on-site tobacco treatment clinic is impactful.

Sections du résumé

BACKGROUND
As a further extension of smoke-free laws in indoor public places and workplaces, the Department of Housing and Urban Development's declaration to propose a regulation that would make housing units smoke-free was inevitable. Of note is the challenge this regulation poses to current tenants of housing units who are active smokers. We aimed to assess the efficacy of a tobacco treatment clinic in public housing. The utilization of the clinic by tenants and tenants' respective outcomes regarding smoking status were used to determine the intervention's effectiveness.
METHODS
Tobacco treatment clinics were held in two urban-based housing units for 1-year. The clinics provided on-site motivational interviewing and prescriptions for pharmacological agents if warranted. Outcomes collected include the tenants' clinic attendance and 3- and 6-month self-reported smoking status.
RESULTS
Twenty-nine tobacco treatment clinic sessions were implemented, recruiting 47 tenants to participate in smoking cessation. The mean age of the cohort was 53 ± 12.3 years old. Of the 47 tenants who participated, 21 (44.7%) attended three or more clinic sessions. At the 3-month mark, five (10.6%) tenants were identified to have quit smoking; at 6-months, 13 (27.7%) tenants had quit smoking. All 13 of the tenants who quit smoking at the end of 6-months attended three or more sessions.
CONCLUSION
An on-site tobacco treatment clinic to provide strategies on smoking cessation was feasible. Efforts are warranted to ensure more frequent follow-ups for tenants aiming to quit smoking. While further resources should be allocated to help tenants comply with smoke-free housing units' regulations, we believe an on-site tobacco treatment clinic is impactful.

Identifiants

pubmed: 34353308
doi: 10.1186/s12889-021-11561-7
pii: 10.1186/s12889-021-11561-7
pmc: PMC8344144
doi:

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1514

Informations de copyright

© 2021. The Author(s).

Références

Am J Public Health. 2004 Feb;94(2):269-78
pubmed: 14759942
Prev Chronic Dis. 2014 Oct 02;11:E171
pubmed: 25275808
MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):103-8
pubmed: 25654612
Nicotine Tob Res. 2006 Feb;8(1):29-36
pubmed: 16497597
Ann Intern Med. 2014 Dec 2;161(11):765-74
pubmed: 25437404
Cochrane Database Syst Rev. 2016 May 27;(5):CD011856
pubmed: 27230795
Prev Chronic Dis. 2015 Jun 25;12:E98
pubmed: 26111158
Respir Care. 2015 Dec;60(12):1796-803
pubmed: 26286738
Nicotine Tob Res. 2009 Jan;11(1):12-24
pubmed: 19246437
Cochrane Database Syst Rev. 2016 Feb 04;2:CD005992
pubmed: 26842828
Am J Prev Med. 2018 Jan;54(1):113-118
pubmed: 29153476
Public Health Rep. 2015 May-Jun;130(3):230-44
pubmed: 25931627
Tob Control. 2015 Nov;24(6):568-73
pubmed: 25015370
BMC Public Health. 2019 Oct 12;19(1):1284
pubmed: 31606051
Addict Behav. 2002 Jul-Aug;27(4):493-507
pubmed: 12188588
CA Cancer J Clin. 2018 Mar;68(2):106-115
pubmed: 29384589
Addiction. 2004 Jan;99(1):29-38
pubmed: 14678060
Tob Control. 2018 Jul;27(e1):e19-e24
pubmed: 29170167
J Aging Soc Policy. 2018 May-Jun;30(3-4):227-243
pubmed: 29634457

Auteurs

Panagis Galiatsatos (P)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. panagis@jhmi.edu.
Medicine for the Greater Good, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA. panagis@jhmi.edu.

Alexandria Soybel (A)

Medicine for the Greater Good, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.

Mandeep Jassal (M)

Division of Pediatric Pulmonary, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Sergio Axel Perez Cruz (SAP)

Medicine for the Greater Good, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.

Caroline Spartin (C)

Medicine for the Greater Good, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.

Katie Shaw (K)

Department of Urban Residency, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Jodi Cunningham (J)

The Community Builders, Inc, Cincinnati, OH, USA.

Norma Fox Kanarek (NF)

Environmental Health and Engineering, Johns Hopkins School of Public Health, Baltimore, MD, USA.
Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH